194 related articles for article (PubMed ID: 11395569)
21. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
Regenass U; Mett H; Stanek J; Mueller M; Kramer D; Porter CW
Cancer Res; 1994 Jun; 54(12):3210-7. PubMed ID: 8205541
[TBL] [Abstract][Full Text] [Related]
22. Ellagic acid inhibits proliferation and induced apoptosis via the Akt signaling pathway in HCT-15 colon adenocarcinoma cells.
Umesalma S; Nagendraprabhu P; Sudhandiran G
Mol Cell Biochem; 2015 Jan; 399(1-2):303-13. PubMed ID: 25355159
[TBL] [Abstract][Full Text] [Related]
23. Effects of the tricyclic nucleoside 6-amino-4-methyl-8-(beta-D-ribofuranosyl)- pyrrolo[4,3,2-de]pyrimido[4,5-c]pyridazine on the viability and cell cycle distribution of L1210 cells in vitro.
Wotring LL; Passiatore JE; Roti Roti JL; Hudson JL; Townsend LB
Cancer Res; 1985 Dec; 45(12 Pt 1):6355-61. PubMed ID: 4063986
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneity of nucleoside transport in mammalian cells. Two types of transport activity in L1210 and other cultured neoplastic cells.
Belt JA
Mol Pharmacol; 1983 Nov; 24(3):479-84. PubMed ID: 6314117
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of 2,4-disubstituted thiazoles and selenazoles as potential antitumor and antifilarial agents: 1. Methyl 4-(isothiocyanatomethyl)thiazole-2-carbamates, -selenazole-2- carbamates, and related derivatives.
Kumar Y; Green R; Borysko KZ; Wise DS; Wotring LL; Townsend LB
J Med Chem; 1993 Nov; 36(24):3843-8. PubMed ID: 8254614
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells.
Uckun FM; Narla RK; Jun X; Zeren T; Venkatachalam T; Waddick KG; Rostostev A; Myers DE
Clin Cancer Res; 1998 Apr; 4(4):901-12. PubMed ID: 9563884
[TBL] [Abstract][Full Text] [Related]
27. Effects of 5-aza-2'-deoxycytidine on survival and cell cycle progression of L1210 leukemia cells.
Chabot GG; Momparler RL
Leuk Res; 1986; 10(5):533-7. PubMed ID: 2423812
[TBL] [Abstract][Full Text] [Related]
28. Modulation of methotrexate resistance by genistein in murine leukemia L1210 cells.
Xuan Y; Hacker MP; Tritton TR; Bhushan A
Oncol Rep; 1998; 5(2):419-21. PubMed ID: 9468571
[TBL] [Abstract][Full Text] [Related]
29. Correlation of biochemical effects and incorporation of 3-deazaguanine into nucleic acids to cytotoxicity in L1210 cells.
Pieper RO; Barrows LR; Mandel HG
Cancer Res; 1986 Oct; 46(10):4960-5. PubMed ID: 3756857
[TBL] [Abstract][Full Text] [Related]
30. A novel synthetic DNA minor groove binder, MS-247: antitumor activity and cytotoxic mechanism.
Matsuba Y; Edatsugi H; Mita I; Matsunaga A; Nakanishi O
Cancer Chemother Pharmacol; 2000; 46(1):1-9. PubMed ID: 10912571
[TBL] [Abstract][Full Text] [Related]
31. Antitumor triptycene bisquinones: a novel synthetic class of dual inhibitors of DNA topoisomerase I and II activities.
Wang B; Perchellet EM; Wang Y; Tamura M; Hua DH; Perchellet JP
Anticancer Drugs; 2003 Aug; 14(7):503-14. PubMed ID: 12960734
[TBL] [Abstract][Full Text] [Related]
32. Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein binding.
Curtin NJ; Bowman KJ; Turner RN; Huang B; Loughlin PJ; Calvert AH; Golding BT; Griffin RJ; Newell DR
Br J Cancer; 1999 Aug; 80(11):1738-46. PubMed ID: 10468290
[TBL] [Abstract][Full Text] [Related]
33. Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells.
Katdare M; Osborne M; Telang NT
Int J Oncol; 2002 Oct; 21(4):809-15. PubMed ID: 12239620
[TBL] [Abstract][Full Text] [Related]
34. The cytotoxic action of 1,3,5-triazabicyclo[3.1.0]hexane-2,4-diones and 1,3,5-triazine-4,6-(1 H,5 H)-diones in murine and human tumor cells.
Hall IH; Taylor K; Izydore RA; Coleman DE; Mitchell JA; Cummings R
Pharmazie; 1998 Jun; 53(6):398-405. PubMed ID: 9675770
[TBL] [Abstract][Full Text] [Related]
35. Conjugated system of homo-aza-steroidal esters in cancer chemotherapy.
Catsoulacos P; Catsoulacos D
Anticancer Res; 1994; 14(6B):2525-8. PubMed ID: 7872677
[TBL] [Abstract][Full Text] [Related]
36. The mechanism of action of quinocarmycin citrate (KW 2152) on mouse L1210 cells in vitro.
Kanamaru R; Konishi Y; Ishioka C; Kakuta H; Sato T; Ishikawa A; Asamura M; Wakui A
Cancer Chemother Pharmacol; 1988; 22(3):197-200. PubMed ID: 3409454
[TBL] [Abstract][Full Text] [Related]
37. Anticancer activities of sesquiterpene lactones from Cyathocline purpurea in vitro.
Ma G; Chong L; Li Z; Cheung AH; Tattersall MH
Cancer Chemother Pharmacol; 2009 Jun; 64(1):143-52. PubMed ID: 18998133
[TBL] [Abstract][Full Text] [Related]
38. Effects of a prospective antitumor agent, 1,4-bis(2'-chloroethyl)-1,4-diazabicyclo-[2.2.1] heptane diperchlorate, on cultured mammalian cells.
Traganos F; Darzynkiewicz Z; Bueti C; Melamed MR
Cancer Invest; 1984; 2(1):1-13. PubMed ID: 6584191
[TBL] [Abstract][Full Text] [Related]
39. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
Kido Y; Khokhar AR; al-Baker S; Siddik ZH
Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
[TBL] [Abstract][Full Text] [Related]
40. P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation.
Gibalová L; Sereš M; Rusnák A; Ditte P; Labudová M; Uhrík B; Pastorek J; Sedlák J; Breier A; Sulová Z
Toxicol In Vitro; 2012 Apr; 26(3):435-44. PubMed ID: 22269388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]